Groundbreaking Discovery: Iowa State Researchers Revolutionize Blood Stem Cell Production

Iowa State researchers make huge discovery for creating blood stem cells in the lab

In an era where scientific breakthroughs are increasingly becoming the bedrock of medical advancements, a team of researchers at Iowa State University has made a monumental discovery that could potentially transform the landscape of regenerative medicine. As reported by Teodora Mitov, their pioneering research has uncovered a possible method to create blood stem cells in […]

Celularity Revolutionizing Cancer Treatment: The Breakthrough of Stem Cell Therapy

celularity-logo

A New Era in Oncology In an exciting development for the field of oncology, Celularity Inc., a leading biotechnology company, is set to present compelling in vivo data at the AACR Annual Meeting 2024. This data showcases the significant impact of their groundbreaking stem cell therapy, PT-CD16, in reducing cancer tumors. Derived from human placental […]

BioCardia Unveils Groundbreaking Results in Phase III CardiAMP Cell Therapy for Heart Failure

BioCardia Logo

BioCardia, Inc., a leader in biotechnological advancements for cardiovascular diseases, recently announced remarkable interim results from its Phase III CardiAMP® Cell Therapy trial for treating advanced chronic heart failure. These findings mark a significant milestone in the pursuit of innovative treatments for heart failure, showcasing the potential of stem cell therapy to revolutionize patient care. […]

Revolutionizing Regenerative Medicine for Hair Loss: Pelage Pharmaceuticals Secures $16.75M Series A Financing Led by GV

Pelage logo

In a groundbreaking move poised to redefine the landscape of regenerative medicine for hair loss, Pelage Pharmaceuticals announces its successful closure of a Series A financing round, securing an impressive $16.75 million. Spearheaded by GV, this investment signals a resounding vote of confidence in Pelage’s innovative approach to addressing one of the most pervasive challenges […]